read more
Transplant Talk: The Nuance of Death Planning
Recorded June 26, 2025 The Nuance of Death Planning: Beyond the Medical Lashanna Williams, Executive Director of A Sacred Passing, …
Antibody-mediated rejection is another form of rejection. This form of rejection is caused by anti-HLA antibodies that target your transplanted lung(s). These antibodies can be present before transplant (especially if you have had a previous pregnancy, transplant, or blood transfusion) or can develop after transplant.
Treatments for antibody-mediated rejection are different than those used for T-lymphocyte rejection. Treatments can include plasmapheresis, intravenous immunoglobulin (IVIG), Rituxan (rituximab), and Velcade (bortezomib).
Recorded June 26, 2025 The Nuance of Death Planning: Beyond the Medical Lashanna Williams, Executive Director of A Sacred Passing, …
Recorded: April 24, 2025 Have you been told that a second transplant may be on your horizon? Are you curious …
Join Anil J. Trindade, MD, Associate Medical Director for Lung Transplantation and the Medical Director for Laryngeal Transplantation at Vanderbilt …
Creating a world where all lung transplant patients live long, healthy lives.
1249 Kildaire Farm Road, Suite 323
Cary, NC 27511
Disclaimer: This website does not provide medical advice. The information, including but not limited to text, graphics, images, and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment before undertaking any new health care regimen. Never disregard any professional medical advice or delay in seeking care because of something you have read on this website.